Established in 2014 by Cancer Research Technologies and Medilink member, the University of Birmingham, Birmingham spinout Revitope Oncology Inc has announced a research collaboration and license agreement with leading Chinese biopharmaceutical company Junshi Biosciences to develop precision cancer therapies that harness the body’s immune response to kill cancer cells while leaving healthy body tissues untouched.
On behalf of the University of Birmingham we would like to invite you to take part in a survey to identify current challenges in regulatory science in healthcare. The aim of the survey is to identify strategic areas for the development of regulatory standards, establish current and future training needs and identify the infrastructure required to support this.
Medilink WM member the University of Birmingham part of the £20m investment ‘COG-UK’ – the new nationwide consortium, COVID-19 Genomics UK Consortium.
Investment of £20m has enabled the formation of a new nationwide consortium to map the spread and evolution of COVID-19 through whole-genome sequencing.
Medilink West Midlands is proud to share the following news article from Birmingham Health Partners, detailing how Medilink member University Of Birmingham is responding to the urgent shortage of hand sanitiser.
Technicians and lab facilities at BHP founder member the University of Birmingham have been redeployed to respond to an urgent shortage of hand sanitiser needed by frontline social care workers to prevent the spread of the Coronavirus.
Artificial intelligence (AI) appears to detect diseases from medical imaging with similar levels of accuracy as healthcare professionals, according to research led by two Birmingham Health Partners (BHP) founder members.
The S2I programme works closley with businesses to understand their technical problem and the impact it has on the business. S2I offers support to SMEs across all sectors including life sciences, medical technologies and advanced manufacturing and engineering.
Scientists at the University of Birmingham have created an antimicrobial coating for steel surfaces which has proven to rapidly kill bacteria that cause some of the most common hospital-acquired infections.